Egg Farmers of Ontario (EFO) is the marketing board for eggs and pullets in Ontario under authority delegated to it by the Ontario Farm Products Marketing Commission. EFO represents the province’s 525 egg and pullet farming families who ensure the production of high-quality eggs for the table and processing markets. Ontario’s egg industry represents farm cash receipts of over $500 million annually and support approximately 7,000 jobs in the province. Each year, EFO invests in research that supports improvements in the egg industry and drives innovation in egg production and pullet rearing.

Each year, Egg Farmers of Ontario (EFO) invests significantly in research that supports improvements in the egg industry and drives innovation.

Economic viability remains a central consideration across all streams of research. The egg industry must remain productive and competitive, and proposed solutions must be both practical and affordable. As such, the potential economic impact of each research proposal will be considered in funding decisions.

For more information about ths funding opportunity, please click here.

Our Fuel program is accepting applications for one more week! Apply now to receive up to $500,000 in funding and a suite of tailored acceleration services to support the development of transformative innovations in aging and brain health.

Fuel supports two streams:

• Healthcare + Research Organizations (HCROs) advancing evidence-based solutions ready for real-world validation

• Start-Up Companies with healthtech or biotech products ready for further development, testing, and validation

Successful applicants also gain access to acceleration services, end-user feedback, expert mentorship, and strategic networks.

The objective of Idea to Innovation (I2I) grants is to accelerate the pre-competitive development of promising technology originating from the university and college sector, and to promote its transfer to a new or established Canadian company. I2I grants provide funding to college and university faculty members to support research and development projects with recognized technology transfer potential. This is achieved through defined phases by providing crucial assistance in the early stages of technology validation and market connection.

• Inclusive collaborator
• Barrier breaker
• Research leader

The Killam NRC Paul Corkum Fellowship may support a specific collaborative project, a knowledge exchange initiative, a novel multidisciplinary collaboration, or other scholarly pursuits that advances knowledge.

The program will award up to three (3) fellowships each year, and each fellowship project must align with an NRC challenge program.

1. enable new and potentially disruptive technologies to be developed with industry, academics and government;
2. strengthen collaborations with industry, academia, and various levels of government to attain critical mass for addressing national issues of importance to the Canadian economy and quality of life for Canadians;
3. find solutions to some of the most serious public policy challenges; and
4. create stronger innovation ecosystems in specific sectors by enabling industry, academics, and government labs to partner with NRC researchers, leveraging NRC facilities and resources, and share knowledge.

Fellowships are valued at $100,000 CAD per year in the form of a grant that is paid to the institution of each Fellow to cover release time. An additional grant of up to $50,000 CAD is available to accommodate travel and knowledge dissemination costs of the Fellow, based on budget estimates provided in the proposal.  Therefore, as part of your application package submitted to the Office of Research Services for review, a complete release time request form would be required (as well as the usual Research Proposal Approval Form).

• Inclusive collaborator
• Barrier breaker
• Research leader 

• demonstrate commitment to building Canada’s future and alignment with Killam attributes
• are mid-career researchers who usually completed their PhD no more than 15 years prior, though special circumstances may result in applicants being more or less than 15 years post-PhD.
• are employed at a Canadian research institution.

The specific objectives of this funding opportunity are to:

1. Establish a national avian influenza research hub that supports the coordination and knowledge mobilization of avian influenza research activities in Canada and internationally, where feasible.
2. Foster collective impact and scientific excellence in avian influenza research by facilitating meaningful and culturally safe engagements between avian influenza researchers and relevant decision-makers and knowledge users from diverse sectors, jurisdictions, and perspectives, such as federal, provincial, territorial, and Indigenous governments, health care providers, non-governmental organizations, industry organizations, and community groups including First Nations, Inuit and Métis communities, where relevant.
3. Facilitate and accelerate the mobilization of knowledge generated from avian influenza research into accessible, usable, timely and relevant solutions and interventions for decision-makers and knowledge users across multiple sectors and jurisdictions, including populations with higher risks of avian influenza exposure and impact (such as veterinarians, livestock producers, trappers, hunters, workers in the agricultural or wildlife sectors, First Nations, Inuit and/or Métis populations, and populations in rural and remote settings).

The objectives of this funding opportunity are to:

• Foster collaborations across Eligible research fields and/or disciplines and the phases of the care continuum to strengthen (Institute of Circulatory and Respiratory Health's) (ICRH's) research community, and prepare funded teams for          interdisciplinary network funding opportunities, to ultimately improve healthcare outcomes.
• Enable researchers to generate preliminary data and/or AI-, computational or digital tools to catalyze future research and innovation, contributing to improving health care aligned with ICRH's mandate.
• Support early career researchers in initiating or participating in interdisciplinary research to build research capacity related to ICRH's mandate.

This Catalyst Funding Opportunity is part of CIHR-ICRH's Reimagine Acute Care initiative, focused on delivering better outcomes for all Canadians through research and evidence-informed decision-making in the research areas defined by ICRH's mandate: the heart; brain (stroke); lung; blood and blood vessels; sleep and critical care.

Conditions within ICRH's mandate represent a significant health challenge in Canada, causing approximately one-third of all deaths and accounting for four of the ten most expensive reasons for hospitalizations. Acute care in the hospital setting accounts for Canada's largest annual health expenditure. Many of these conditions, such as heart failure, asthma, and high blood pressure, are Ambulatory Care Sensitive Conditions where hospitalization may be avoided if managed with timely pre-acute care interventions. Late arrival to hospital care leads to complications, longer stays, and chronic disease development. Importantly, acute care access and outcomes are also largely influenced by social and economic factors. Therefore, certain groups like low income, rural and remote, racialized, immigrant and Indigenous populations experience additional barriers to optimal outcomes. Taken together, these observations highlight the need for a more integrated research approach to prevent or improve acute care outcomes.

• Innovations in Cost-Disruptive Tools for Diagnosis and Screening: This request for proposals (RFP) seeks cost-disruptive devices and diagnostics that cost less than US$1 per test or person, that can stand up to the real-world constraints of frontline public health, and that provide rapid, reliable results.
• Novel Interventions Targeting Placental and Gut Inflammation to Improve Fetal Growth: There are currently no scalable, effective therapies that directly prevent or reverse fetal growth restriction, which affects more than 20 million infants annually. This RFP is designed to accelerate the discovery and development of interventions targeting maternal gut–placenta inflammatory axes and oxidative stress to improve fetal growth outcomes.
• Addressing Physiological Barriers to Micronutrient Absorption from Fortified Foods: This RFP seeks innovative approaches to overcome the biological constraints that limit people's ability to absorb micronutrients in fortified foods in high-burden settings, such as chronic inflammation and gut barrier dysfunction.
• Cost-Disrupting Innovations to Reduce the Cost of Ready-to-Use Therapeutic Food: With increasingly constrained resources to address Severe Acute Malnutrition, this RFP seeks innovative approaches that will reduce the cost of Ready-to-Use Therapeutic Foods (RUTF) in Sub-Saharan Africa and South Asia by at least 30%.
• Breakthrough Innovations to Significantly Reduce the Cost of Severe Acute Malnutrition Treatment: This RFP seeks transformative, system-level innovations that can substantially increase the number of children treated per dollar spent by reducing the total cost per child treated—without changing the ex-factory price of Ready-to-Use Therapeutic Foods (RUTF) or substituting RUTF with an alternative product.
• Artificial Intelligence (AI) to Accelerate Charitable Giving: This RFP seeks ideas that use AI to connect potential donors (from everyday givers to established foundations) to the causes they care about and make it easier for them to contribute.

Applications for all RFPs are due no later than April 28, 2026, at 11:30 AM Pacific Daylight Time.

We will host a dedicated webinar on each RFP to provide more details and answer your questions. Please check the challenge page of the RFP you are interested in for exact dates and times. The webinars will be recorded and available for viewing after the session.